Table 3 Previously published rates of toxicity following prostate SBRT
Study | n | Dose/Fractions | Timepoint | Genitourinary Toxicity | Gastrointestinal Toxicity | ||
|---|---|---|---|---|---|---|---|
Grade 2 | ≥ Grade 3 | Grade 2 | ≥ Grade 3 | ||||
Madsen [10] | 40 | 33.5/5 | Within or after 1 month | Acute 20.5% | Acute 2.5% | Acute 13% | Acute 0% |
Late 20% | Late 0% | Late 7.5% | Late % | ||||
Tang [12] | 30 | 35/5 | ≤6 months | 13% | 0% | 7% | 0% |
King [9] | 41 | 36.25/5 | ≥6 months | 24% | 5% | 15% | 0% |
McBride [11] | 34 | 37.5–36.25/5 | Within or after 3 months | Acute 19% | Acute 0% | Acute 7% | Acute 0% |
Late 17% | Late 2% | Late 7% | Late 5% | ||||
Hannan [8] | 91 | 45–50/5 | Within or after 9 months | Acute 22% | Acute 0% | Acute 20.9% | Acute 2.2% |
Late 20.9% | Late 5.5% | Late 13.2% | Late 6.6% | ||||
Alonghi [7] | 40 | 35/5 | Within or after 6 months | Acute 40% | Acute 0% | Acute 10% | Acute 0% |
Late 2.5% | Late 0% | Late 0% | Late 0% | ||||